Subarachnoid hemorrhage (SAH) is an acute cerebrovascular event which can have
devastating effects on the central nervous system as well as a profound impact on several …

Subarachnoid hemorrhage (SAH), predominantly caused by a ruptured aneurysm, is a
devastating neurological disease that has a morbidity and mortality rate higher than 50 …

Background The neurointensive care management of patients with aneurysmal
subarachnoid hemorrhage (aSAH) is one of the most critical components contributing to …

Despite improvements in the clinical management of aneurysmal subarachnoid
haemorrhage over the last decade, delayed cerebral ischaemia (DCI) remains the single …

Cerebral vasospasm has traditionally been regarded as an important cause of delayed
cerebral ischaemia (DCI) which occurs after aneurysmal subarachnoid haemorrhage, and …

Growing evidences suggest that stroke is a systemic disease affecting many organ systems
beyond the brain. Stroke-related systemic inflammatory response and immune …

Background The benefit of statins in patients with acute aneurysmal subarachnoid
haemorrhage is unclear. We aimed to determine whether simvastatin 40 mg could improve …

Aneurysmal subarachnoid hemorrhage (aSAH) continues to be associated with significant
morbidity and mortality despite advances in care and aneurysm treatment strategies …

As it is often assumed that delayed cerebral ischemia (DCI) after subarachnoid hemorrhage
(SAH) is caused by vasospasm, clinical trials often focus on prevention of vasospasm with …

Background: Aneurysmal subarachnoid hemorrhage (aSAH) is associated with high
mortality and morbidity. We aimed to determine the relative benefits of pharmacological …